[A case of interstitial pneumonia associated with dermatomyositis effectively treated with cyclosporin-A and cyclophosphamide pulse].

نویسندگان

  • Takuya Kotani
  • Shigeki Makino
  • Yoshiko Kawasaki
  • Suzue Hirano
  • Youko Tabushi
  • Maki Kagitani
  • Toru Takeuchi
  • Toshiaki Hanafusa
چکیده

A 46-year-old male demonstrated edematous fingers on both hands in November 2003, and interstitial pneumonia was noted on chest X-ray during a medical check-up in December 2003. Since muscular weakness and fever developed thereafter, and interstitial pneumonia was aggravated on chest X-ray and CT, the patient was admitted to our hospital on March 25, 2004. Heliotrope-like erythema, and Gottron's sign were noted. Laboratory findings showed the following ; LDH 876 U/l ; CK 224 U/l ; CRP 5.68 mg/dl ; and KL-6 3270 U/ml. Autoantibodies such as anti-Jo-1 antibody were all negative. Chest X-ray and CT showed ground-glass opacity in the bilateral lower dorsal regions of the lung, and reduced volume of the inferior lobe. He was diagnosed as having dermatomyositis (DM) associated with progressive interstitial pneumonia. Although a combination of steroid pulse therapy and Cyclosporin-A were administered, the pulmonary lesions became aggravated. Additional intravenous Cyclophosphamide (IVCY) was initiated on the 6th hospital day, and interstitial pneumonia was markedly improved. Cases of progressive interstitial pneumonia associated with DM that are negative for anti-Jo-1 antibody and show a low ratio of CK/LDH are resistant to various treatments. Our case suggested that combination therapy with steroid, Cyclosporin-A, and IVCY is useful for the treatment of progressive interstitial pneumonia with DM.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Cyclosporine treatment for interstitial pneumonitis associated with dermatomyositis/polymyositis.

Weread with interest the case report by Shinohara et al (1) and the editorial by Takizawa and Ito (2). Shinohara et al described a case of rapidly progressive interstitial lung disease associated with dermatomyositis (DM) who was successfully treated with cyclophosphamide pulse therapy. The case report and the editorial by Takizawa et al commenton the use of cyclosporine for this intractable in...

متن کامل

Cyclophosphamide pulse therapy for rapidly progressive interstitial pneumonia in dermatomyositis. A new possibility for rescue?

Dermatomyositis (DM) is a systemic inflammatory disorder characterized by profound lesions in muscles and skin (1). This disease is associated with pulmonary lesions which include aspiration pneumonia, infections, drug-induced pneumonia as well as interstitial lung disease (ILD) (2). ILD in DMhas been reported as one of the systemic lesions of this autoimmune disease of unknown etiology (3), an...

متن کامل

Cytokine profiles of amyopathic dermatomyositis with interstitial lung diseases treated with mycophenolate

A 59-year-old Japanese man diagnosed with interstitial lung disease associated with amyopathic dermatomyositis with anti-melanoma differentiation-associated gene 5 (MDA-5) antibodies was treated with intravenous methyl prednisolone (PSL) 1000 mg, oral PSL 1 mg/kg, and oral cyclosporin 200 mg daily. His respiratory condition worsened after treatment with two times of intravenous cyclophosphamide...

متن کامل

[Anti-MDA5 (melanoma differentiation-associated gene 5) antibody and dermatomyositis with rapidly progressive interstitial pneumonia].

Anti-MDA5 antibody is one of the dermatomyositis-specific autoantibodies and anti-MDA5-potsitive patients show characteristic clinical features, such as hypomyositis, high prevalence of acute/subacute interstitial pneumonia (A/SIP) with poor prognosis, hyperferritinemia and elevated hepatobiliary enzyme. We found that serum IL-6, IL-18, M-CSF and IL-10 were significantly higher and serum IL-12 ...

متن کامل

Interstitial lung disease associated with juvenile dermatomyositis: clinical features and efficacy of cyclosporin A.

OBJECTIVES Interstitial lung disease (ILD) is a rare complication of juvenile dermatomyositis (JDM). The aim of this study was to clarify the clinical features of JDM-associated ILD and to evaluate the efficacy of cyclosporin A (CSA). METHODS We reviewed clinical records of 10 cases of JDM that were admitted to Hokkaido University Hospital between April 1990 and March 2001. RESULTS Five cas...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology

دوره 28 3  شماره 

صفحات  -

تاریخ انتشار 2005